China A-share CRO sector strengthened, with Aopumai up more than 6% and Wanbang
Pharmaceutical rising over 4%; Heyuan Bio, Xinghao Pharmaceutical and Baihua
Pharmaceutical also advanced.
2026-10-29
China A-share CRO sector strengthened, with Aopumai up more than 6% and Wanbang
Pharmaceutical rising over 4%; Heyuan Bio, Xinghao Pharmaceutical and Baihua
Pharmaceutical also advanced.